21Shares Dogecoin ETF (TDOG): Entry into a Material Definitive Agreement

21Shares Dogecoin ETF (TDOG) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Benchmark Licensing Agreement On August 20, 2026, 21Shares US LLC (the “Sponsor”) entered into a licensing agreement (the “Benchmark Licensing Agreement”) with FTSE International Limited (“FTSE” or the “Benchmark Provider”). E

Event · Contract
Role
customer
Counterparty
FTSE International Limited
Duration
one-year initial term
Scope
FTSE Dogecoin Index

Facts are quoted from the filing text and checked against it.

Original reporting
Published Aug 26, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$TDOG
Neutral
high confidence
Mentioned
$TDOG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TDOGNeutralMed
01

Why it matters

The agreement updates the ETF's pricing methodology and sponsor fee schedule, which may affect NAV calculation and investor perception.

02

Market read

A primary SEC filing announcing a new benchmark for a crypto ETF, potentially affecting its tracking and investor demand.

03

What to watch

Potential regulatory scrutiny of crypto benchmarks could affect long‑term viability.

Relevance 6/10Novelty 8/10Timing: filed Aug 26 2026

Background

21Shares Dogecoin ETF (TDOG) previously used the CF Dogecoin‑Dollar US Settlement Price Index; the new FTSE Dogecoin Index replaces it.

Company-level read

Ticker impact

$TDOGNeutralHigh confidence
Context

21Shares Dogecoin ETF filed an 8‑K reporting a new Benchmark Licensing Agreement with FTSE, changing its pricing benchmark and sponsor fee terms.

Expected impact

Modest upside if market views the FTSE index as higher quality.

Evidence & confidence

The filing is a primary disclosure of a material corporate action; no prior public notice existed.

Market effects

May influence other crypto‑linked ETFs that rely on similar benchmarks.

Limited to U.S. listed crypto ETF market.

Highlights growing institutional infrastructure for crypto pricing.

Counterpoint

If investors view the FTSE index as untested, the change could raise concerns about tracking error.

Key entities

  • 21Shares US LLC

    Issuer of the Dogecoin ETF filing the 8‑K.

  • FTSE International Limited

    Provider of the new Dogecoin Index.

Related articles

$CLPTMed

ClearPoint Neuro Raises ATM Offering Capacity to $150 Million With Stifel

ClearPoint Neuro (CLPT) increased its ATM offering capacity to $150M from $50M via an amended agreement with Stifel. The company can sell shares through Stifel, with $27.5M available under the current prospectus. Additional sales require a new supplement. CLPT controls timing, price, and size of sales, paying up to 3% in commissions. The amendment was signed and effective on Nov 18, 2026.

$ASTSMed

AST SpaceMobile Sinks 8% as New Offering Filing Revives Dilution Fears

AST SpaceMobile (ASTS) fell 8% after filing for a new securities sale, raising dilution concerns. The company's share count rose from 200M to 300M between late 2024 and Q3 2026. AT&T (T) and Vodafone (VOD), which have stakes in AST, are also affected. AST's free cash flow was negative $1.8B over the last four quarters, with analysts expecting negative free cash flow through 2028.